Mucopolysaccharidosis Type IIIA

Hematopoietic Stem ◽

Type Iiia ◽

Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report

Molecular Genetics and Metabolism Reports ◽

10.1016/j.ymgmr.2014.09.003 ◽

2014 ◽

Vol 1 ◽

pp. 422-424 ◽

Cited By ~ 5

Author(s):

Erlane Marques Ribeiro ◽

Ana Carolina Brusius-Facchin ◽

Sandra Leistner-Segal ◽

Carlos Antônio Bruno da Silva ◽

Ida Vanessa Schwartz

Keyword(s):

Case Report ◽

Cardiac Disease ◽

Type Iiia ◽

Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery

The Journal of Gene Medicine ◽

10.1002/jgm.2816 ◽

2014 ◽

Vol 16 (11-12) ◽

pp. 374-387 ◽

Cited By ~ 10

Author(s):

Chantelle McIntyre ◽

Ainslie L. K. Derrick-Roberts ◽

Sharon Byers ◽

Donald S. Anson

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Gene Delivery ◽

Central Nervous System Pathology ◽

Type Iiia ◽

Characterization of Sulfated Oligosaccharides in Mucopolysaccharidosis Type IIIA by Electrospray Ionization Mass Spectrometry

Analytical Chemistry ◽

10.1021/ac052083d ◽

2006 ◽

Vol 78 (13) ◽

pp. 4534-4542 ◽

Cited By ~ 28

Author(s):

Kerryn E. Mason ◽

Peter J. Meikle ◽

John J. Hopwood ◽

Maria Fuller

Keyword(s):

Mass Spectrometry ◽

Electrospray Ionization ◽

Electrospray Ionization Mass Spectrometry ◽

Ionization Mass Spectrometry ◽

Ionization Mass ◽

Sulfated Oligosaccharides ◽

Type Iiia ◽

Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA

Experimental Neurology ◽

10.1016/j.expneurol.2018.01.020 ◽

2018 ◽

Vol 303 ◽

pp. 38-47 ◽

Cited By ~ 7

Author(s):

Dani L. Webber ◽

Amanda Choo ◽

Laura J. Hewson ◽

Paul J. Trim ◽

Marten F. Snel ◽

...

Keyword(s):

Heparan Sulfate ◽

Pathogenic Mechanisms ◽

Type Iiia ◽

Interim results of Transpher A, a multicenter, single-dose, phase 1/2 clinical trial of ABO-102 gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA)

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2019.11.129 ◽

2020 ◽

Vol 129 (2) ◽

pp. S56-S57 ◽

Cited By ~ 1

Author(s):

Kevin M. Flanigan ◽

Nicholas J.C. Smith ◽

Maria Luz Couce ◽

Kristen V. Truxal ◽

Kim L. McBride ◽

...

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Single Dose ◽

Phase 1 ◽

Type A ◽

Syndrome Type ◽

Sanfilippo Syndrome ◽

Type Iiia ◽

Design and rationale of the LYS-SAF302 gene therapy study in mucopolysaccharidosis type IIIA (MPS IIIA) children

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2018.12.283 ◽

2019 ◽

Vol 126 (2) ◽

pp. S111-S112

Author(s):

Sophie Olivier ◽

Samantha Parker ◽

Anupam Chakrapani ◽

Ronald Crystal ◽

Lisa Emrick ◽

...

Keyword(s):

Gene Therapy ◽

Type Iiia ◽

Mps Iiia ◽

Pentosan Polysulfate Treatment of Mucopolysaccharidosis Type IIIA Mice

JIMD Reports - JIMD Reports, Volume 43 ◽

10.1007/8904_2018_96 ◽

2018 ◽

pp. 37-52 ◽

Cited By ~ 4

Author(s):

Ningning Guo ◽

Victor DeAngelis ◽

Changzhi Zhu ◽

Edward H. Schuchman ◽

Calogera M. Simonaro

Keyword(s):

Pentosan Polysulfate ◽

Type Iiia ◽

A novel mutation of SGSH and clinical features analysis of mucopolysaccharidosis type IIIA

Medicine ◽

10.1097/md.0000000000013758 ◽

2018 ◽

Vol 97 (52) ◽

pp. e13758 ◽

Cited By ~ 1

Author(s):

Xiaohua Li ◽

Rui Xiao ◽

Baiyu Chen ◽

Guanglu Yang ◽

Xiaomeng Zhang ◽

...

Keyword(s):

Clinical Features ◽

Novel Mutation ◽

Type Iiia ◽

Lentiviral mediated stem cell gene therapy corrects a mouse model of mucopolysaccharidosis type IIIA

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2010.11.026 ◽

2011 ◽

Vol 102 (2) ◽

pp. S8

Author(s):

Brian Bigger ◽

Alex Langford-Smith ◽

Fiona Wilkinson ◽

Kia Langford-Smith ◽

Ana Sergijenko ◽

...

Keyword(s):

Gene Therapy ◽

Stem Cell ◽

Mouse Model ◽

Type Iiia ◽

Cell Gene ◽

Mucopolysaccharidosis Type Iiia ◽

Stem Cell Gene ◽

Stem Cell Gene Therapy